Immunex Enbrel panel on Tuesday

The FDA's Arthritis Drugs Advisory Committee will consider on Tuesday IMNX's application to expand the indications for the company's Enbrel TNF inhibitor to include patients with early rheumatoid

Read the full 281 word article

How to gain access

Continue reading with a
two-week free trial.